Search research articles
Contact Us
Filters
Showing results (841-850 of 881) with videos related to
Page
of 89
Sort By:
Microbiome
|
July 1, 2026
Museomics reveals uncultured symbionts with biosynthetic potential in nudibranchs
Dafne Porcel Sanchis, Marta Pola, J Pamela Engelberts, et al.
BMC Cardiovascular Disorders
|
December 9, 2025
Integrated bioinformatic and in vivo analysis confirms the cardioprotective role of OPA1
Claire Fong-McMaster, Serena M Pulente, Luke S Kennedy, et al.
Mabs
|
August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
Maxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.
Human Genetics
|
May 22, 2003
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease
Denise Harold, Timothy Peirce, Valentina Moskvina, et al.
Journal of Hematology & Oncology
|
January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Plos Pathogens
|
January 23, 2025
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies
Peter R McIlroy, Le Thanh Mai Pham, Thomas Sheffield, et al.
Geroscience
|
June 7, 2025
Subcortical white matter hyperintensities and motor function in parkinson's disease: findings from the ONDRI study
Daniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Anthony E Lang, et al.
Pathology
|
July 4, 2017
Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy
Fedaa Najdawi, Ashley Crook, Jayne Maidens, et al.
BMC Geriatrics
|
April 18, 2018
SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment
Manuel Montero-Odasso, Quincy J Almeida, Amer M Burhan, et al.
Blood
|
April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial
Sridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Page
of 89
Search research articles
Search
Showing results (841-850 of 881) with videos related to
Sort By:
Page
of 89
Microbiome
|
July 1, 2026
Museomics reveals uncultured symbionts with biosynthetic potential in nudibranchs
Dafne Porcel Sanchis, Marta Pola, J Pamela Engelberts, et al.
BMC Cardiovascular Disorders
|
December 9, 2025
Integrated bioinformatic and in vivo analysis confirms the cardioprotective role of OPA1
Claire Fong-McMaster, Serena M Pulente, Luke S Kennedy, et al.
Mabs
|
August 4, 2021
Development of potent and effective synthetic SARS-CoV-2 neutralizing nanobodies
Maxwell A Stefan, Yooli K Light, Jennifer L Schwedler, et al.
Human Genetics
|
May 22, 2003
Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease
Denise Harold, Timothy Peirce, Valentina Moskvina, et al.
Journal of Hematology & Oncology
|
January 10, 2022
Impaired neutralisation of SARS-CoV-2 delta variant in vaccinated patients with B cell chronic lymphocytic leukaemia
Helen Parry, Graham McIlroy, Rachel Bruton, et al.
Plos Pathogens
|
January 23, 2025
Nanobody screening and machine learning guided identification of cross-variant anti-SARS-CoV-2 neutralizing heavy-chain only antibodies
Peter R McIlroy, Le Thanh Mai Pham, Thomas Sheffield, et al.
Geroscience
|
June 7, 2025
Subcortical white matter hyperintensities and motor function in parkinson's disease: findings from the ONDRI study
Daniela Cristina Carvalho de Abreu, Frederico Pieruccini-Faria, Anthony E Lang, et al.
Pathology
|
July 4, 2017
Lessons learnt from implementation of a Lynch syndrome screening program for patients with gynaecological malignancy
Fedaa Najdawi, Ashley Crook, Jayne Maidens, et al.
BMC Geriatrics
|
April 18, 2018
SYNERGIC TRIAL (SYNchronizing Exercises, Remedies in Gait and Cognition) a multi-Centre randomized controlled double blind trial to improve gait and cognition in mild cognitive impairment
Manuel Montero-Odasso, Quincy J Almeida, Amer M Burhan, et al.
Blood
|
April 21, 2024
Ibrutinib as part of risk-stratified treatment for posttransplant lymphoproliferative disorder: the phase 2 TIDaL trial
Sridhar Chaganti, Shanna Maycock, Graham McIlroy, et al.
Page
of 89